Characterization of the Human Cytomegalovirus Envelope Glycoproteins

References

1. Bonner W. M., Laskey R. A. 1974; A film detection method for tritium-labeled proteins and nucleic acids in polyacrylamide gels. European Journal of Biochemistry 46:83–88
   [Google Scholar]
2. Clark B. R., Zaia J. A., Balce-Directo L., Ting Y. P. 1984; Isolation and partial chemical characterisation of a 64000 dalton glycoprotein of human cytomegalovirus. Journal of Virology 49:279–282
   [Google Scholar]
3. Cohen G. L., Katz M., Hydrean-Stern C., Gisenberg R. J. 1978; Type common Gp-1 antigen of herpes simplex virus is associated with a 59000 molecular weight envelope glycoprotein. Journal of Virology 27:172–181
   [Google Scholar]
4. Fiala M., Honess R. W., Heiner D. C., Heine J. W., Murnane J., Wallace R., Guze L. B. 1976; Cytomegalo-virus proteins. I. Polypeptides of virions and dense bodies. Journal of Virology 19:243–254
   [Google Scholar]
5. Furukawa T., Gonczol E., Starr S., Tolpin M. D., Arbeter A., Plotkin S. A. 1984; HCMV envelope antigens induce both humoral and cellular immunity in guinea pig. Proceedings of the Society for Experimental Biology and Medicine 175:243–250
   [Google Scholar]
6. Gahmberg C. G., Hakomori S. I. 1973; External labelling of cell surface galactose and galactosamine in glyco-lipid and glycoprotein of human erythrocytes. Journal of Biological Chemistry 248:4311–4317
   [Google Scholar]
7. Gibson W. 1983; Protein counterparts of human and simian cytomegalovirus. Virology 128:391–406
   [Google Scholar]
8. Gupta P., StJeor S., Rapp F. 1977; Comparison of the polypeptides of several strains of human cytomegalovirus. Journal of General Virology 34:447–454
   [Google Scholar]
9. Hunter W. M., Greenwood F. C. 1962; Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature, London 194:495–496
   [Google Scholar]
10. Irmiere A., Gibson W. 1983; Isolation and characterisation of a non-infectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 130:118–133
    [Google Scholar]
11. Kim K. S., Sapienza V. J., Carp R. I., Moon H. M. 1976; Analysis of structural polypeptides of purified human cytomegalovirus. Journal of Virology 20:604–611
    [Google Scholar]
12. Laemmli U.K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
13. Morgan A. J., Smith A. R., Barker R. N., Epstein M. A. 1984; A structural investigation of the Epstein-Barr (EB) virus membrane antigen glycoprotein, gp340. Journal of General Virology 65:397–404
    [Google Scholar]
14. Norrild B. 1980; Immunochemistry of herpes simplex virus glycoproteins. Current Topics in Microbiology and Immunology 90:67–106
    [Google Scholar]
15. North J. R., Morgan A. J., Thompson J. L., Epstein M. A. 1982; Purified EB virus gp 340 induces potent virus neutralising antibodies when incorporated in liposomes. Proceedings of the National Academy of Sciences, U. S. A 79:7504–7508
    [Google Scholar]
16. Nowak B., Sullivan C., Sirnow P., Thomas R., Bircont F., Nicolas I. C., Fleckenstein B., Levine A. J. 1984; Characterisation of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology 132:325–338
    [Google Scholar]
17. Pereira L., Hoffman M., Cremer N. 1982; Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus infected cell extracts by human sera. Infection and Immunity 36:933–942
    [Google Scholar]
18. Plummer G. 1973; Cytomegaloviruses of man and animals. Progress in Medical Virology 15:92–125
    [Google Scholar]
19. Reynolds D. W., Stagno S., Alford C. A. 1979; Laboratory diagnosis of cytomegalovirus infections. In Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections 5th edn pp 399–439 Edited by Lennette E. H., Schmidt N. J. Washington, D.C.: American Public Health Association;
    [Google Scholar]
20. Severi B., Landini M. P., Musiahi M., Zerbini M. 1979; A study of the passage of human cytomegalovirus from the nucleus to the cytoplasm. Microbiologica 2:265–273
    [Google Scholar]
21. Smith J. D., De Harven E. 1973; Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. I.Sequence of viral replication. Journal of Virology 12:919–930
    [Google Scholar]
22. Spear P. G. 1980; Cell membranes and viral envelopes. In Herpesviruses vol 2: pp 709–750 Edited by Blough H. A., Tiffany J. M. New York: Academic Press;
    [Google Scholar]
23. Stinski M. F. 1976; Human cytomegalovirus: glycoproteins associated with virions and dense bodies. Journal of Virology 19:594–609
    [Google Scholar]
24. Stinski M. F. 1977; Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. Journal of Virology 23:751–767
    [Google Scholar]
25. Stinski M. F. 1978; Sequence of protein synthesis in cells infected by human cytomegalovirus. Early and late virus-induced polypeptides. Journal of Virology 26:686–701
    [Google Scholar]
26. Stinski M. F., Mocarski E. S., Thomsen D. R., Urbanowski M. L. 1979; Membrane glycoproteins and antigens induced by human cytomegalovirus. Journal of General Virology 43:119–129
    [Google Scholar]
27. Strange R. E., Powell E. O., Pearce T. W. 1971; The rapid detection and determination of sparse bacterial populations with radioactively labelled homologous antibodies. Journal of General Microbiology 67:349–357
    [Google Scholar]
28. Talbot P., Almeida J. D. 1977; Human cytomegalovirus: purification of enveloped virions and dense bodies. Journal of General Virology 36:345–349
    [Google Scholar]
29. Thorley-Lawson D. A., Geilinger K. 1980; Monoclonal antibodies against the major glycoprotein (gp 350/220) of Epstein-Barr virus neutralise infectivity. Proceedings of the National Academy of Sciences, U. S. A 77:5307–5311
    [Google Scholar]
30. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U. S. A 76:4350–4354
    [Google Scholar]
31. Weller T. H. 1971; The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. New England Journal of Medicine 285:203–214
    [Google Scholar]